| 1. | Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am CollCardiol, 2017, 70(2): 252-289. | 
				                                                        
				                                                            
				                                                                | 2. | Ribeiro HB, Nombela-Franco L, Urena M, et al. Coronary obstruction following transcatheter aortic valve implantation: a systematic review. JACC Cardiovasc Interv, 2013, 6(5): 452-461. | 
				                                                        
				                                                            
				                                                                | 3. | Eugenio S, Giovanni S, Cioppa A, et al. Acute left main obstructions following TAVI. EuroIntervention, 2010, 6(1): 100-105. | 
				                                                        
				                                                            
				                                                                | 4. | Seipelt RG, Hanekop GG, Schoendube FA, et al. Heart team approach for transcatheter aortic valve implantation procedures complicated by coronary artery occlusion. Interact Cardiovasc Thorac Surg, 2012, 14(4): 431-433. | 
				                                                        
				                                                            
				                                                                | 5. | Franco A, Gerli C, Ruggeri L, et al. Anaesthetic management of transcatheter aortic valve implantation. Ann Card Anaesth, 2012, 15(1): 54-63. | 
				                                                        
				                                                            
				                                                                | 6. | Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation insights from a large multicenter registry. J Am Colle Cardiol, 2013, 62(17): 1552-1562. | 
				                                                        
				                                                            
				                                                                | 7. | Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Colle Cardiol, 2010, 55(11): 1080-1090. | 
				                                                        
				                                                            
				                                                                | 8. | Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation, 2010, 122(1): 62-69. | 
				                                                        
				                                                            
				                                                                | 9. | Ruggeri L, Gerli C, Franco A, et al. Anesthetic management for percutaneous aortic valve implantation: an overview of worldwide experiences. HSR Proc Intensive Care Cardiovasc Anesth, 2012, 4(1): 40-46. |